Godrej Agrovet Ltd
Godrej Agrovet Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management said on revenue, margins and capex.
Get Godrej Agrovet Ltd's next results in your feed
Guidance rank: #23 of 31 in Food Products
See the sector's top 10 — free with your mobile number.
The short version
Overall top-line growth for FY '26 is expected in the early teens, with a 16%-18% growth guidance maintained. Top-line growth for Godrej Agrovet Limited (GAVL) expected in early teens for FY '26 with profit growth maintained as per Q1 FY '26.
From Godrej Agrovet Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Overall top-line growth for FY '26 is expected in the early teens, with a 16%-18% growth guidance maintained. (Page 5)
- Crop protection standalone revenue growth is uncertain currently due to poor Hitweed product performance; better clarity expected after 3-4 weeks. (Page 15)
- Astec LifeSciences aims for EBITDA break-even in FY '26, targeting Rs. 500 crore turnover with CDMO and new products growing over 30% annually beyond FY '26. (Pages 6, 13-14)
- CDMO business revenue target is over Rs. 300 crore in FY '26, making up 65% of total sales. (Page 13)
- Ashitaka herbicide has a theoretical market potential of about Rs. 200 crore over 3-4 years, with corn acreage growth supporting this. (Page 6)
2 more points from Godrej Agrovet Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Godrej Agrovet Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Significant investments made recently include close to Rs. 1,250 crores in the last six months for buying out partners in Godrej Foods and Creamline Dairy to achieve 100% ownership, enabling cleaner portfolio decisions (Page 12).
- Refitting of old plants for commercializing new CDMO products is planned; current new projects will be based on existing old plants with multipurpose capabilities allowing adjustments and refitting as needed (Page 13).
- Mention of CapEx in last 2-3 years involving new plants to support CDMO products signifies ongoing capacity-building investments (Page 13).
- Growth in CDMO business and new product launches imply continued strategic investments.
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Godrej Agrovet Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Godrej Agrovet Ltd said on order book & pipeline — free account, 30 seconds.
Godrej Agrovet Ltd — Quarterly revenue & net profit
Godrej Agrovet Ltd Q1 FY26 results — key figures
| ₹ Cr | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 2,614 | 2,351 | +11.2% | 2,134 | +22.5% |
| Operating profit (EBITDA) | 270 | 226 | +19.5% | 147 | +83.7% |
| Operating margin | 10% | 10% | 0 pp | 7% | +3 pp |
| Profit before tax | 200 | 166 | +20.5% | 87 | +129.9% |
| Net profit (PAT) | 149 | 132 | +12.9% | 66 | +125.8% |
| EPS (₹) | 8.35 | 7.03 | +18.8% | 3.68 | +126.9% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.3K Cr, net profit ₹102 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Godrej Agrovet's management said in earlier quarters
Others in Food Products this season
- Prataap Snacks (Q1 FY26)
Q1 FY26 sales/income from operations: INR 4,089.4 Mn, down 2.4% YoY from INR 4,191.3 Mn in Q1 FY25 (Page 26). Key concall takeaways from Prataap Snacks Ltd's…
- Sharat Industrie (Q1 FY26)
Revenue from Operations for Q1FY26 is ₹115.19 Cr, up from ₹89.80 Cr in Q1FY25, reflecting a strong year-on-year growth. Key concall takeaways from Sharat…
- Freshara Agro (Q1 FY26)
FY25 Total Revenue: ₹250.64 Cr (₹25,063.55 Lakhs) . Key concall takeaways from Freshara Agro Exports Ltd's Q1 FY26 earnings call — and how it ranks against…
- Hatsun Agro (Q1 FY26)
The impact of GST rate reduction on dairy products from 12% to 5%. Key concall takeaways from Hatsun Agro Product Ltd's Q1 FY26 earnings call — and how it…
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Godrej Agrovet Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Godrej Agrovet Ltd Q1 FY26 results?
Overall top-line growth for FY '26 is expected in the early teens, with a 16%-18% growth guidance maintained. Top-line growth for Godrej Agrovet Limited (GAVL) expected in early teens for FY '26 with profit growth maintained as per Q1 FY '26.
What is Godrej Agrovet Ltd share price analysis?
Godrej Agrovet Ltd currently shows a neutral. The stock trades at a P/E of 23.8 with a market cap of ₹11,166 Cr. Investors should review the full earnings analysis for detailed insights.
Is Godrej Agrovet Ltd planning capital expenditure?
Significant investments made recently include close to Rs. 1,250 crores in the last six months for buying out partners in Godrej Foods and Creamline Dairy to achieve 100% ownership, enabling cleaner p.
Keep Godrej Agrovet Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.